Author

Anup Malani

  • Antitrust

    Reverse Settlements, Part 4: What Is the Baseline?

    By Anup Malani In my final post on reverse settlements I want to offer three thoughts that are more directly related to the legal question of how to treat reverse settlements under antitrust law. First,…

    Reverse Settlements, Part 4: What Is the Baseline?

  • Antitrust

    Reverse Settlements, Part 3: Value of a Drug Patent

    By Anup Malani In this third post on reverse settlements, I examine whether traditional legal standards for judging whether a drug patent is valid captures the social value from a drug patent.  This is important…

    Reverse Settlements, Part 3: Value of a Drug Patent

  • Biotechnology

    Reverse settlements, Part 2: drug company profits

    By Anup Malani In my second post, I want  continue my discussion of reverse settlements.  Recall that the basic argument against reverse settlements is that they extend the duration of a pioneer drug company’s patent…

    Reverse settlements, Part 2: drug company profits

  • Biotechnology

    A different perspective on reverse settlements

    By Anup Malani  Before I begin my initial post, I want to thank Holly for inviting me to post on this blog. I want to take up reverse settlements in litigation over pharmaceutical patents. Circuits…

    A different perspective on reverse settlements